The role of transrectal ultrasound and biopsy in the diagnosis and management of prostate cancer

Imaging

Volumn 20, Issue 2, 2008, Pages 122-130

  Lee, L ^a   Pilcher, J ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CONTRAST MEDIUM; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTATE SPECIFIC ANTIGEN;

ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; BACTEREMIA; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SIZE; CANCER STAGING; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; DOPPLER ECHOGRAPHY; EPIDIDYMITIS; GLEASON SCORE; HEMATURIA; HEMOSPERMIA; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE QUALITY; LOCAL ANESTHESIA; LYMPH NODE METASTASIS; LYMPHADENECTOMY; NEEDLE BIOPSY; ORGAN BLOOD FLOW; PATIENT SAFETY; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; RECTOSCOPY; SYNCOPE; TRANSRECTAL ULTRASONOGRAPHY; TRANSURETHRAL RESECTION; URINARY TRACT INFECTION; URINE RETENTION;

EID: 55849098549     PISSN: 09656812     EISSN: None     Source Type: Journal    
DOI: 10.1259/imaging/41490379     Document Type: Article

References (40)

1. Toms JR (editor). Cancerstats. London: Cancer Research UK, 2004.
2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
3. UK Prostate Cancer incidence statistics. http://info.cancerresearchuk.org/cancerstats/types/prostate/incidence/ ?a55441#source12. Accessed January 2007.
4. Cooperberg MR, Broering JM, Latini DM, Litwin MS, Wallace KL, Carroll PR. Patterns of practice in the United States: insights from CaPSURE on prostate cancer management. Curr Urol Rep 2004;5:166-72.
5. Klotz L. Low-risk prostate cancer can and should often be managed with active surveillance and selective delayed intervention. Nat Clin Pract Urol 2008;5:2-3.
6. Mistry K, Cable G. Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma. J Am Board Fam Pract 2003;16:95-101.
7. Prostate Cancer Risk Management Programme Group. NHS making progress on prostate cancer. Department of Health Publications 265065, 2004.
8. Coley CM, Barry MJ, Fleming C, Mulley AG. Early detection of prostate cancer. Part I: prior probability and effectiveness of tests. The American College of Physicians. Ann Intern Med 1997;126:394-406.
9. Onur R, Littrup PJ, Pontes JE, Bianco FJ, Jr. Contemporary impact of transrectal ultrasound lesions for prostate cancer detection. J Urol 2004;172:512-4.
10. Raja J, Ramachandran N, Munneke G, Patel U. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol 2006;61:142-53.
11. Patel U, Rickards D. The diagnostic value of colour Doppler flow in the peripheral zone of the prostate, with histological correlation. Br J Urol 1994;74:590-5.
12. Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: contrast-enhanced US for detection. Radiology 2001;219:219-25.
13. Rubens DJ, Hadley MA, Alam SK, Gao L, Mayer RD, Parker KJ. Sonoelasticity imaging of prostate cancer: in vitro results. Radiology 1995;195:379-83.
14. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988;12:897-906.
15. NHS Cancer Screening Programmes. Diagnostic value of systematic prostate biopsy. Methods in the investigation for prostate cancer. York: University of York Centre for Reviews and Dissemination, 2005.
16. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-4.
17. Prostate Cancer Risk Management Programme Group. Undertaking a transrectal ultrasound guided biopsy of the prostate. Department of Health Publications, 2006. http://www.cancerscreening.nhs.uk/prostate/ pcrmp01.pdf. [Accessed January 2007.]
18. Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int 2004;94:1014-20.
19. Máan Z, Cutting CW, Patel U, Kerry S, Pietrzak P, Perry MJ, et al. Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin. BJU Int 2003;91:798-800.
20. Kravchick S, Peled R, Ben Dor D, Dorfman D, Kesari D, Cytron S. Comparison of different local anesthesia techniques during TRUS-guided biopsies: a prospective pilot study. Urology 2005;65:109-13.
21. Trucchi A, De Nunzio C, Mariani S, Palleschi G, Miano L, Tubaro A. Local anesthesia reduces pain associated with transrectal prostatic biopsy. A prospective randomized study. Urol Int 2005;74:209-13.
22. Borboroglu PG, Comer SW, Riffenburgh RH, Amling CL. Extensive repeat transrectal ultrasound guided prostate biopsy in patients with previous benign sextant biopsies. J Urol 2000;163:158-62.
23. Donzella JG, Merrick GS, Lindert DJ, Andreini HJ, Jr., Curtis RL, Luna IH, et al. Epididymitis after transrectal ultrasound-guided needle biopsy of prostate gland. Urology 2004;63:306-8.
24. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997;157:199-202.
25. Naughton CK, Ornstein DK, Smith DS, Catalona WJ. Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores. J Urol 2000;163:168-71.
26. Stewart CS, Leibovich BC, Weaver AL, Lieber MM. Prostate cancer diagnosis using a saturation needle biopsy technique after previous negative sextant biopsies. J Urol 2001;166:86-91.
27. Ramachandran N, MacKinnon A, Allen C, Dundas D, Patel U. Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications. Clin Radiol 2005;60:1130.
28. Webb NR, Woo HH. Antibiotic prophylaxis for prostate biopsy. BJU Int 2002;89:824-8.
29. Taylor HM, Bingham JB. The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy. Clin Radiol 1997;52:787-90.
30. Lee G, Attar K, Laniado M, Karim O. Trans-rectal ultrasound guided biopsy of the prostate: nationwide diversity in practice and training in the United Kingdom. Int Urol Nephrol 2007;39:185-8.
31. Gilad J, Borer A, Maimon N, Riesenberg K, Klein M, Schlaeffer F. Failure of ciprofloxacin prophylaxis for ultrasound guided transrectal prostatic biopsy in the era of multiresistant enterobacteriaceae. J Urol 1999;161: 222.
32. Irani J, Fournier F, Bon D, Gremmo E, Dore B, Aubert J. Patient tolerance of transrectal ultrasound-guided biopsy of the prostate. Br J Urol 1997;79:608-10.
33. Seymour H, Perry MJ, Lee-Elliot C, Dundas D, Patel U. Pain after transrectal ultrasonography-guided prostate biopsy: the advantages of periprostatic local anaesthesia. BJU Int 2001;88:540-4.
34. Patel HR, Lee F, Arya M, Masood S, Palmer JH, Sheriff MK. A national survey of transrectal ultrasound-guided prostatic biopsies: time for a national guideline. Int J Clin 2003;57:773-4.
35. Davis M, Sofer M, Kim SS, Soloway MS. The procedure transrectal ultrasound guided biopsy of the prostate: survey of patient preparation and biopsy technique. J 2002;167:566-70.
36. Obek C, Onal B, Ozkan B, Onder AU, Yalcin V, Solok V. Is periprostatic local anesthesia for transrectal ultrasound guided prostate biopsy associated with increased infectious or hemorrhagic complications? A prospective randomized trial. J Urol 2002;168:558-61.
37. Albertsen PC, Hanley JA, Gleason DF, Barry MJ. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. JAMA 1998;280:975-80.
38. Donovan JL, Frankel SJ, Faulkner A, Selley S, Gillatt D, Hamdy FC. Dilemmas in treating early prostate cancer: evidence and a questionnaire survey of consultant urologists in the United Kingdom. BMJ 1999;318:299-300.
39. Prostate Cancer v.2.2007. National Comprehensive Cancer Network Clinical Practice Guideline in Oncology. http://www.nccn.org/professionals/ physician_gls/PDF/prostate.pdf. [Accessed January 2007.]
40. Royal College of Radiologists. Recommendations for cross-sectional imaging in cancer management, Issue 2. Royal College of Radiologists, 2006. http://www.rcr.ac.uk/index.asp?PageID=149&PublicationID=227. [Accessed January 2007.]